These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 39208641)
1. Crystal structure of an antibody specifically recognizing 3,4-methyl enedioxy methamphetamine through the epoxide moiety. Cheon G; Hwang D; Le TC; Lee Y; Han E; An S; Jung Y; Chung H; Lee S Biochem Biophys Res Commun; 2024 Nov; 733():150607. PubMed ID: 39208641 [TBL] [Abstract][Full Text] [Related]
2. Crystal structures of a therapeutic single chain antibody in complex with two drugs of abuse-Methamphetamine and 3,4-methylenedioxymethamphetamine. Celikel R; Peterson EC; Owens SM; Varughese KI Protein Sci; 2009 Nov; 18(11):2336-45. PubMed ID: 19760665 [TBL] [Abstract][Full Text] [Related]
3. Structural characterization of a therapeutic anti-methamphetamine antibody fragment: oligomerization and binding of active metabolites. Peterson EC; Celikel R; Gokulan K; Varughese KI PLoS One; 2013; 8(12):e82690. PubMed ID: 24349338 [TBL] [Abstract][Full Text] [Related]
4. Chemical cousins with contrasting behavioural profiles: MDMA users and methamphetamine users differ in social-cognitive functions and aggression. Zacher A; Zimmermann J; Cole DM; Friedli N; Opitz A; Baumgartner MR; Steuer AE; Verdejo-Garcia A; Stock AK; Beste C; Quednow BB Eur Neuropsychopharmacol; 2024 Jun; 83():43-54. PubMed ID: 38642447 [TBL] [Abstract][Full Text] [Related]
6. N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats. Glennon RA; Young R; Dukat M; Chang-Fong J; El-Zahabi M Pharmacol Biochem Behav; 2007 Mar; 86(3):477-84. PubMed ID: 17307247 [TBL] [Abstract][Full Text] [Related]
7. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472 [TBL] [Abstract][Full Text] [Related]
8. Effects of 3,4-methylenedioxymethamphetamine and methamphetamine on motor vehicle driving performance: A systematic review of experimental and observational studies. McGrane IR; Ramsbacher NC; Rook WC; Omar FA J Forensic Sci; 2023 Jan; 68(1):22-34. PubMed ID: 36411495 [TBL] [Abstract][Full Text] [Related]
9. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Clemens KJ; McGregor IS; Hunt GE; Cornish JL Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831 [TBL] [Abstract][Full Text] [Related]
10. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats. Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443 [TBL] [Abstract][Full Text] [Related]
11. Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation. Garcia-Ratés S; Camarasa J; Escubedo E; Pubill D Toxicol Appl Pharmacol; 2007 Sep; 223(3):195-205. PubMed ID: 17614110 [TBL] [Abstract][Full Text] [Related]
12. Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats. Clemens KJ; Cornish JL; Hunt GE; McGregor IS Drug Alcohol Depend; 2007 Jan; 86(2-3):183-90. PubMed ID: 16884865 [TBL] [Abstract][Full Text] [Related]
13. The ecstasy and the agony; compression studies of 3,4-methylenedioxymethamphetamine (MDMA). Connor LE; Delori A; Hutchison IB; Nic Daeid N; Sutcliffe OB; Oswald ID Acta Crystallogr B Struct Sci Cryst Eng Mater; 2015 Feb; 71(Pt 1):3-9. PubMed ID: 25643710 [TBL] [Abstract][Full Text] [Related]
14. Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity. Itzhak Y; Anderson KL; Ali SF Ann N Y Acad Sci; 2004 Oct; 1025():119-28. PubMed ID: 15542708 [TBL] [Abstract][Full Text] [Related]
16. Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251. Nawata Y; Kitaichi K; Yamamoto T Drug Alcohol Depend; 2016 Mar; 160():76-81. PubMed ID: 26796595 [TBL] [Abstract][Full Text] [Related]
17. Conflict monitoring and emotional processing in 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine users - A comparative neurophysiological study. Opitz A; Zimmermann J; Cole DM; Coray RC; Zachäi A; Baumgartner MR; Steuer AE; Pilhatsch M; Quednow BB; Beste C; Stock AK Neuroimage Clin; 2024; 41():103579. PubMed ID: 38447413 [TBL] [Abstract][Full Text] [Related]
18. Oral administration of (+/-)3,4-methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques. Crean RD; Davis SA; Taffe MA Pharmacol Biochem Behav; 2007 May; 87(1):11-9. PubMed ID: 17475314 [TBL] [Abstract][Full Text] [Related]
19. Causes and consequences of methamphetamine and MDMA toxicity. Quinton MS; Yamamoto BK AAPS J; 2006 May; 8(2):E337-47. PubMed ID: 16796384 [TBL] [Abstract][Full Text] [Related]
20. Intravenous methamphetamine self-administration in rats: effects of intravenous or intraperitoneal MDMA co-administration. Clemens KJ; Cornish JL; Hunt GE; McGregor IS Pharmacol Biochem Behav; 2006 Oct; 85(2):454-63. PubMed ID: 17112571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]